AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in Multiple Myeloma Treatment
The chapter explores the latest developments in treating multiple myeloma, discussing promising drugs like bollantima methadotin, mesicdomide, and i bertimide, highlighting their efficacy and potential benefits. It also touches on the use of bi-specific antibodies and CAR-T treatments for long-term disease control, emphasizing the importance of diverse treatment options. Dr. Richardson expresses optimism for the future of myeloma treatment, acknowledging the contributions of younger investigators and patient advocacy groups in advancing research and care.